Vertex Pharmaceuticals Inc (VRTX) — Technical state
As of 2026-11-13 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Closelooknet score: 55 out of 100 (momentum 81 · quality 82 · valuation 24), as of 2026-11-17.
- Signal: -0.7% at the close — Holding 5.3% off its 52-week high. (as of 2026-11-13)
- Trend: Vertex Pharmaceuticals Inc trades 3.1% above its 50-day and 11.4% above its 200-day moving average. (as of 2026-11-13)
- Index seat: HALO Growth 100
Vertex Pharmaceuticals is a biotechnology company that sells drugs for cystic fibrosis, a lung and digestive disease caused by a faulty gene, including its main products Trikafta and Kaftrio. It also markets Casgevy, a gene-edited therapy for sickle cell disease and transfusion-dependent beta thalassemia, and Journavx for acute pain.
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the VRTX overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.
Holding 5.3% off its 52-week high.
The moving-average stack
- vs 20-day+0.5%
- vs 50-day+3.1%
- vs 200-day+11.4%
- 52-week band5.3% off the high · +33.8% off the low
- Streak4 consecutive down sessions
- Stochastic%K 56.4 · %D 61.4 · down cross
Continue: the VRTX chart & overview · quality & forensics · the earnings record · the signal board
FAQ · from the current data · as of 2026-11-13
Quick answers
What is the current Closelooknet signal on VRTX?
-0.7% at the close — Holding 5.3% off its 52-week high. As of 2026-11-13; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is VRTX above its 50-day and 200-day moving averages?
As of 2026-11-13, Vertex Pharmaceuticals Inc trades +3.1% above its 50-day and +11.4% above its 200-day average, with the 20-day +0.5% away.
How far is VRTX from its 52-week high?
5.3% below the 52-week high and 33.8% above the 52-week low, as of 2026-11-13.
Mentioned on Closelooknet
Where VRTX appears in the diary — 1 piece, newest first. Every link is our own writing.
Go deeper
Dailies
- A chart pick published at 95.10 this morning trades 107.92 by midday — Robinhood's triangle breaks up through the 100 shelf — as the CAC snaps seven straight red sessions and Bitcoin adds another six percent above 77,000
Barchart's large-cap 52-week new-high list, as of 11:59 CDT, carries 31 names and reads like the ex-tech thesis printed as breadth: twelve are health care, biotech or pharma — ARGX, BDX, BIO, CORT, HALO, MRK, REGN, RVTY, THC, TVTX, TXG…
Related in the Closelooknet universe
same Closelooknet index seat first, then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- WISE.L Wise plc
- DECK Deckers Outdoor Corporation
- LLY Eli Lilly and Company
- DXCM DexCom Inc
- TOST Toast Inc
- HDB HDFC Bank Limited ADR
- VRSK Verisk Analytics Inc
- GMED Globus Medical
- IDXX IDEXX Laboratories Inc
- DB1.DE Deutsche Börse AG
- ELF ELF Beauty Inc
- FAST Fastenal Company
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- UCB.BR UCB SAindustry
- ARGX argenx NV ADRindustry
- PTGX Protagonist Therapeutics Incindustry
- BION.SW BB Biotech AGindustry
- REPL Replimune Group Incindustry
- VCEL Vericel Corp Ordindustry